Angiostatin ELISA Kit

Produktnummer ABIN624941

Produktdetails Angiostatin ELISA Kit

Target: Angiostatin (ANG)

Reaktivität: Human

Nachweismethode: Colorimetric

Methodentyp: Sandwich ELISA

Detektionsbereich: 20-2000 ng/mL

Untere Nachweisgrenze: 20 ng/mL

Applikation: ELISA

Verwendungszweck: Human Angiostatin ELISA Kit for cell culture supernatants, plasma, and serum samples.

Proben: Plasma, Cell Culture Supernatant, Serum

Analytische Methode: Quantitative

Spezifität: This ELISA kit shows no cross-reactivity with any of the cytokines tested: human Angiopoietin-1, B7-1, BMP-7, CD14, CD30, CD40, CD40 Ligand, CTLA-4, CXCL16, Dkk-4 , DR6, Endostatin, E-Selectin, Follistatin, HB-EGF, HVEM, ICAM-2, IGF-II, IL-10 Ra, IL-10 Rb, IL-18, IL-9 , IL-2 Ra, IL-2 Rb, IL-5 Ra, LAP, L-Selectin, M-CSF R, MMP-2, 3, 7, 8, 9, 10 and 12, PDGF-AB, SDF-1b, Tie-1, Tie-2, TIMP-3.

Sensitivität: 20000 pg/mL

Produktmerkmale:

• Strip plates and additional reagents allow for use in multiple experiments
• Quantitative protein detection
• Establishes normal range
• The best products for confirmation of antibody array data

Bestandteile:

• Pre-Coated 96-well Strip Microplate
• Wash Buffer
• Stop Solution
• Assay Diluent(s)
• Lyophilized Standard
• Biotinylated Detection Antibody
• Streptavidin-Conjugated HRP
• TMB One-Step Substrate

Benötigtes Material:

• Distilled or deionized water
• Precision pipettes to deliver 2 μL to 1 μL volumes
• Adjustable 1-25 μL pipettes for reagent preparation
• 100 μL and 1 liter graduated cylinders
• Tubes to prepare standard and sample dilutions
• Absorbent paper
• Microplate reader capable of measuring absorbance at 450nm
• Log-log graph paper or computer and software for ELISA data analysis

Anwendungsinformationen

Applikationshinweise: Recommended Dilution for serum and plasma samples3 - 30 fold

Probenmenge: 100 μL

Plattentyp: Pre-coated

Protokoll:

1. Prepare all reagents, samples and standards as instructed in the manual.
2. Add 100 μL of standard or sample to each well.
3. Incubate 2.5 h at RT or O/N at 4 °C.
4. Add 100 μL of prepared biotin antibody to each well.
5. Incubate 1 h at RT.
6. Add 100 μL of prepared Streptavidin solution to each well.
7. Incubate 45 min at RT.
8. Add 100 μL of TMB One-Step Substrate Reagent to each well.
9. Incubate 30 min at RT.
10. Add 50 μL of Stop Solution to each well.
11. Read at 450 nm immediately.

Aufbereitung der Reagenzien:

1. Bring all reagents and samples to room temperature (18 - 25 °C) before use.
   2. Sample dilution: If your samples need to be diluted, 1x Assay Diluent (Item E) should be used for dilution of serum/plasma/ culture supernantants/urine samples. Suggested dilution for normal serum/plasma: 3-30 fold. Please note that levels of the target protein may vary between different specimens. Optimal dilution factors for each sample must be determined by the investigator.
   3. Assay Diluent (Item E) should be diluted 5-fold with deionized or distilled water before use.
   4. Preparation of standard: Briefly spin the vial of Item C and then add 800 µL 1x Assay Diluent (Item E, Assay Diluent should be diluted 5-fold with deionized or distilled water) into Item C vial to prepare a 2,000 ng/mL standard. Dissolve the powder thoroughly by a gentle mix. Pipette 300myl 1x Assay Diluent into each tube. Use the 2,000 ng/mL standard to produce a dilution series . Mix each tube thoroughly before the next transfer. 1x Assay Diluent serves as the zero standard (0 ng/mL). 300 µL 300 µL 300 µL 300 µL 300 µL 300myl 800 µL 1x Assay Diluent 2,000 1,000 500 250 125 62.5 31.25 0 ng/mL ng/mL ng/mL ng/mL ng/mL ng/mL ng/mL ng/mL
   5. If the Wash Concentrate (20x) (Item B) contains visible crystals, warm to room temperature and mix gently until dissolved. Dilute 20 ml of Wash Buffer Concentrate into deionized or distilled water to yield 400 ml of 1x Wash Buffer.
   6. Briefly spin the Detection Antibody vial (Item F) before use. Add 100 µL of 1x Assay Diluent into the vial to prepare a detection antibody concentrate. Pipette up and down to mix gently (the concentrate can be stored at 4 °C for 5 days). The detection antibody concentrate should be diluted 80-fold with 1x Assay Diluent and used in step 4 of Part VI Assay Procedure.
   7. Briefly spin the HRP-Streptavidin concentrate vial (Item G) before use. HRP-Streptavidin concentrate should be diluted 800-fold with 1x Assay Diluent. For example: Briefly spin the vial (Item G) and pipette up and down to mix gently . Add 15 µL of HRP-Streptavidin concentrate into a tube with 12 ml 1x Assay Diluent to prepare a final 800 fold diluted HRP-Streptavidin solution (don't store the diluted solution for next day use). Mix well.

Testdurchführung:

1. Bring all reagents and samples to room temperature (18 - 25 °C) before use. It is recommended that all standards and samples be run at least in duplicate.
   2. Add 100 µL of each standard (see Reagent Preparation step 2) and sample into appropriate wells. Cover well and incubate for 2.5 hours at room temperature or over night at 4 °C with gentle shaking.
   3. Discard the solution and wash 4 times with 1x Wash Solution. Wash by filling each well with Wash Buffer (300 myl) using a multi-channel Pipette or autowasher. Complete removal of liquid at each step is essential to good performance. After the last wash, remove any remaining Wash Buffer by aspirating or decanting. Invert the plate and blot it against clean paper towels.
   4. Add 100 µL of 1x prepared biotinylated antibody (Reagent Preparation step 6) to each well. Incubate for 1 hour at room temperature with gentle shaking.
   5. Discard the solution. Repeat the wash as in step
   6. Add 100 µL of prepared Streptavidin solution (see Reagent Preparation step 7) to each well. Incubate for 45 minutes at room temperature with gentle shaking.
   7. Discard the solution. Repeat the wash as in step
   8. Add 100 µL of TMB One-Step Substrate Reagent (Item H) to each well. Incubate for 30 minutes at room temperature in the dark with gentle shaking.
   9. Add 50 µL of Stop Solution (Item I) to each well. Read at 450 nm immediately.

Ergebnisberechnung:

Calculate the mean absorbance for each set of duplicate standards, controls and samples, and subtract the average zero standard optical density. Plot the standard curve on log-log graph paper or using Sigma plot software, with standard concentration on the x-axis and absorbance on the y-axis. Draw the best-fit straight line through the standard points.
Typical Data: These standard curves are for demonstration only. A standard curve must be run with each assay. Assay Diluent Human Angiostatin concentration (ng/mL) O D =4 50 n m 0.01 0.1 1 10 10 100 1,000 10,000
Sensitivity: The minimum detectable dose of Angiostatin is typically less than 20 ng/mL.
Recovery: Recovery was determined by spiking various levels of human Angiostatin into human serum, plasma and cell culture media. Mean recoveries are as follows: Sample Type Average % Recovery Range ( %) Serum 92.45 81-101 Plasma 93.31 82-102 Cell culture media 95.43 83-104
Linearity: Sample Type Serum Plasma Cell Culture Media 1:2 Average % of Expected 91 92 93 Range ( %) 81-101 82-102 83-103 1:4 Average % of Expected 93 95 96 Range ( %) 82-102 83-103 85-104
Reproducibility: Intra-Assay: CV<10 % Inter-Assay: CV<12 %

Testpräzision: Intra-Assay: CV< 10 % Inter-Assay: CV< 12 %

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Handhabung: Avoid repeated freeze-thaw cycles.

Lagerung: -20 °C

Informationen zur Lagerung: The entire kit may be stored at -20°C for up to 1 year from the date of shipment. Avoid repeated freeze-thaw cycles. The kit may be stored at 4°C for up to 6 months. For extended storage, it is recommended to store at -80°C.

Haltbarkeit: 6 months

Referenzen für Angiostatin ELISA Kit (ABIN624941)

Oh, Park, Song, Lee, Cho, Kim, Chu, Choi, Park: "Radiation-induced angiogenic signaling pathway in endothelial cells obtained from normal and cancer tissue of human breast." in: Oncogene, Vol. 33, Issue 10, pp. 1229-38, (2014) (PubMed).

Wertenbroek, Schepers, Kamminga-Rasker, Bottema, Muller Kobold, Roelofsen, de Jong: "Clinical outcome, proteome kinetics and angiogenic factors in serum after thermoablation of colorectal liver metastases." in: BMC cancer, Vol. 13, pp. 266, (2014) (PubMed).

Keskin, Keskin, Inal, Oz???k: "Serum angiostatin levels in patients with Behçet's disease: does angiogenesis play a role in the pathogenesis of Behçet's disease?" in: Acta clinica Belgica, Vol. 69, Issue 4, pp. 246-50, (2014) (PubMed).

Pflum, Palumbo, Li: "Adverse effect of demineralized bone powder on osteogenesis of human mesenchymal stem cells." in: Experimental cell research, Vol. 319, Issue 13, pp. 1942-55, (2013) (PubMed).

Park, Oh, Song, Lee, Park: "Radio-sensitivities and angiogenic signaling pathways of irradiated normal endothelial cells derived from diverse human organs." in: Journal of radiation research, Vol. 53, Issue 4, pp. 570-80, (2012) (PubMed).

Navarro-Sobrino, Rosell, Hernández-Guillamon, Penalba, Boada, Domingues-Montanari, Ribó, Alvarez-Sabín, Montaner: "A large screening of angiogenesis biomarkers and their association with neurological outcome after ischemic stroke." in: Atherosclerosis, Vol. 216, Issue 1, pp. 205-11, (2011) (PubMed).

Yamahara, Min, Tomoike, Kangawa, Kitamura, Nagaya: "Pathological role of angiostatin in heart failure: an endogenous inhibitor of mesenchymal stem-cell activation." in: Heart (British Cardiac Society), Vol. 95, Issue 4, pp. 283-9, (2009) (PubMed).

Cao, OReilly, Marshall, Flynn, Ji, Folkman: "Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases." in: The Journal of clinical investigation, Vol. 101, Issue 5, pp. 1055-63, (1998) (PubMed).

Dong, Kumar, Yang, Fidler: "Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma." in: Cell, Vol. 88, Issue 6, pp. 801-10, (1997) (PubMed).

Details zu Angiostatin

Target: Angiostatin (ANG)

Andere Bezeichnung: Angiostatin (ANG Produkte)

Synonyme: ALS9 ELISA Kit, HEL168 ELISA Kit, RNASE4 ELISA Kit, RNASE5 ELISA Kit, LPA ELISA Kit, AI649309 ELISA Kit, Pg ELISA Kit, Ab1-346 ELISA Kit, AI385586 ELISA Kit, Ang1 ELISA Kit, Rnase5 ELISA Kit, Rnase5a ELISA Kit, angiogenin ELISA Kit, plasminogen ELISA Kit, angiogenin, ribonuclease, RNase A family, 5 ELISA Kit, ANG ELISA Kit, PLG ELISA Kit, Plg ELISA Kit, Ang ELISA Kit

Hintergrund: Angiostatin was observed initially as an angiogenesis inhibitor in serum and urine of mice bearing a Lewis lung carcinoma (3LL cells). Angiostatin is produced by the protelytic cleavage of plasminogen by a serine protease from several human prostate carcinoma cell lines. The production of Angiostatin by human pancreatic cancer cells can be inhibited by TGF-beta-1 in participation with plasminogen activator inhibitor type-1. Angiostatin specifically inhibits endothelial cell proliferation. In an animal tumor model the factor produced by the primary tumor suppresses the growth of its remote metastases, which neovascularize and grow after tumor removal. The Human Angiostatin ELISA (Enzyme-Linked Immunosorbent Assay) kit is an in vitro enzyme-linked immunosorbent assay for the quantitative measurement of human Angiostatin in serum, plasma (heparin), cell culture supernatants and urine. This assay employs an antibody specific for human Angiostatin coated on a 96-well plate. Standards and samples are pipetted into the wells and Angiostatin present in a sample is bound to the wells by the immobilized antibody. The wells are washed and biotinylated anti-human Angiostatin antibody is added. After washing away unbound biotinylated antibody, HRP-conjugated streptavidin is pipetted to the wells. The wells are again washed, a TMB substrate solution is added to the wells and color develops in proportion to the amount of Angiostatin bound. The Stop Solution changes the color from blue to yellow, and the intensity of the color is measured at 450 nm. Reproducibility: Intra-Assay: CV<10% Inter-Assay: CV<12%.

Gen-ID: 5340

UniProt: P00747

Pathways: Lipid Metabolism